Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia

BACKGROUND: Although chronic urticaria (CU) is a common, cause of medical consulting both in general practitioners and allergist specialists worldwide, there is little information about its behavior and management in Latin America. Currently, national and international guidelines recommend using Oma...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Gómez, Elizabeth, Chapman, Edgardo, García-Paba, María Beatriz, Ocampo-Gómez, Jaime, Egea-Bermejo, Eduardo, Garavito-De Egea, Gloria, Fang, Luis, Sarrazola, Mauricio, Sánchez-Caraballo, Jorge Mario, Serrano-Reyes, Carlos, Silva-Espinosa, Diana Lucia, Rojas-Mejía, Dolly Vanessa, Moreno, Sergio M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234875/
https://www.ncbi.nlm.nih.gov/pubmed/35769574
http://dx.doi.org/10.3389/falgy.2022.902344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234875/
https://www.ncbi.nlm.nih.gov/pubmed/35769574
http://dx.doi.org/10.3389/falgy.2022.902344

Ejemplares similares